5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells, J Biol Chem, vol.260, pp.6107-6114, 1985. ,
Identification of yeast and human 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAr) transporters, J Biol Chem, vol.289, pp.16844-16854, 2014. ,
AMPK-sensing energy while talking to other signaling pathways, Cell Metab, vol.20, pp.939-952, 2014. ,
AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts, Apoptosis, vol.18, pp.1008-1016, 2013. ,
AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells, Blood, vol.116, pp.3023-3032, 2010. ,
Identification of aneuploidy-selective antiproliferation compounds, Cell, vol.144, pp.499-512, 2011. ,
Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-beta-riboside-induced apoptosis in multiple myeloma cells, Mol Cancer Ther, vol.12, pp.1310-1321, 2013. ,
Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death, PLoS One, pp.4-7889, 2009. ,
, , 2013.
, Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation, Oncogene, vol.32, pp.3139-3146
Does aneuploidy cause cancer?, Curr Opin Cell Biol, vol.18, pp.658-667, 2006. ,
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis, Proc Natl Acad Sci U S A, vol.106, pp.12932-12937, 2009. ,
Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis, PLoS One, 2013. ,
AMPK and PPARdelta agonists are exercise mimetics, Cell, vol.134, pp.405-415, 2008. ,
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study, Cancer Chemother Pharmacol, vol.71, pp.581-591, 2013. ,
Differential effects of AMPK agonists on cell growth and metabolism, Oncogene, vol.34, pp.3627-3639, 2015. ,
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK, Proc Natl Acad Sci U S A, vol.111, pp.435-444, 2014. ,
AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside, Biochem J, vol.404, pp.499-507, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00478741
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments, Mol Cell Biol, vol.26, pp.5336-5347, 2006. ,
The Hippo pathway: regulators and regulations, Genes Dev, vol.27, pp.355-371, 2013. ,
YAP and TAZ: a nexus for Hippo signaling and beyond, Trends Cell Biol, vol.25, pp.499-513, 2015. ,
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data, Nat Genet, vol.29, pp.365-371, 2001. ,
Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma, Proc Natl Acad Sci U S A, vol.107, pp.15553-15558, 2010. ,
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition, J Biol Chem, vol.284, pp.13355-13362, 2009. ,
TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors, Nat Cell Biol, vol.17, pp.615-626, 2015. ,
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth, Nat Cell Biol, vol.17, pp.1218-1227, 2015. ,
Mechanisms of Hippo pathway regulation, Genes Dev, vol.30, pp.1-17, 2016. ,
Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway, Sci Signal, vol.7, p.29, 2014. ,
, , 2012.
, Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP, Dev Biol, vol.367, pp.187-196
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway, Nat Cell Biol, vol.17, pp.500-510, 2015. ,
Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene, Cell Rep, vol.8, pp.707-713, 2014. ,
The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner, Oncogene, vol.34, pp.4190-4198, 2015. ,
5-Aminoimidazole-4-carboxamide-1--beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects, vol.2, pp.292-302, 2012. ,
Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP, Acta Crystallogr D Biol Crystallogr, vol.63, pp.587-596, 2007. ,
LATS tumor suppressor: a new governor of cellular homeostasis, Cell Cycle, vol.9, pp.3892-3903, 2010. ,
YAP/TAZ at the Roots of Cancer, Cancer Cell, vol.29, pp.783-803, 2016. ,
The Hippo pathway and human cancer, Nat Rev Cancer, vol.13, pp.246-257, 2013. ,
The emerging roles of YAP and TAZ in cancer, Nat Rev Cancer, vol.15, pp.73-79, 2015. ,
The Hippo Pathway: A Master Regulatory Network Important in Development and Dysregulated in Disease, Curr Top Dev Biol, vol.123, pp.181-228, 2017. ,
Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase, PNAS, vol.104, pp.819-822, 2007. ,
AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis, Cancer Res, vol.74, pp.4783-4795, 2014. ,
, , 2012.
, Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression, Biochem Pharmacol, vol.83, pp.385-394
AMPK modulates Hippo pathway activity to regulate energy homeostasis, Nat Cell Biol, vol.17, pp.490-499, 2015. ,
Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways, Trends Cell Biol, vol.26, pp.289-299, 2016. ,
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERalpha, Nature, vol.541, pp.541-545, 2017. ,
for cancer prevention and treatment, Oncotarget, vol.6, pp.7365-7378, 2015. ,